发明名称 Tetraaza-cyclopenta[a]indenyl derivatives
摘要 The present invention provides compounds of Formula (I) as M1 receptor positive allosteric modulators for the treatment of diseases mediated by the muscarinic M1 mediator.;
申请公布号 US9505769(B2) 申请公布日期 2016.11.29
申请号 US201414896757 申请日期 2014.06.12
申请人 Asceneuron SA 发明人 Quattropani Anna;Kulkarni Santosh S.;Murugesan Kathiravan;Banerjee Joydeep
分类号 C07D487/04;A61K31/519;A61K31/5377;C07D519/00;C07D487/12 主分类号 C07D487/04
代理机构 Saul Ewing LLP 代理人 Saul Ewing LLP ;Doyle Kathryn;Silva Domingos J.
主权项 1. A compound of Formula (I): wherein R1 and R3 are independently from each other selected from the group consisting of H and linear or branched C1-C6-alkyl, R2 is selected from the group consisting of chloro, linear or branched C1-C6-alkyl and C3-C7 cycloalkyl, R4 is selected from the group consisting of F and H, and R5 is selected from the group consisting of A and CH2CH2R7, wherein A is selected from the group consisting of:wherein R6 is selected from the group consisting of H, CH3, CH2CH2R, CH(CH2R)2, CH2CR3, CH2-cyclopropyl, CH2CN, and CH2CHF2, R6′ is selected from the group consisting of CH2CH2R′, CH(CH2R′)2, CH2CR3, and CH2CO2R1, R6″ is selected from the group consisting of F, OH, OCH3, NH2, N(CH3)2, N(R1)2, and CO2R1, R6′″ is selected from the group consisting of CH2CH2R, CH(CH2R)2, CH2CR3, CH2-cyclopropyl, CH2CN, and CH2CHF2, R is selected from the group consisting of H, CN, OH, OCH3, Cl, F, CHF2, CH3, CF3, CH2CH3 and cyclopropyl, R′ is selected from the group consisting of CN, OH, OCH3, Cl, CHF2, CH3, CF3 and cyclopropyl, and R7 is selected from the group consisting of: wherein Ra and Rb are each independently selected from the group consisting of H, F, CH3, OCH3, OH and 1-pyrrolidinyl and at least one of Ra and Rb is selected from the group consisting of F, CH3, OCH3, OH and 1-pyrrolidinyl, or tautomers, salts, solvates, stereoisomers, diastereomers and enantiomers thereof.
地址 Lausanne CH